Martin Shkreli
martin@martinshkreli.com
←
|
ARWR.xlsx
|
Main
JNJ-3989
fazirsiran
APOC3
ANG3
RAGE
olpasiran
A
B
C
1
Main
2
Brand
AMG 890, ARO-LPA
3
Generic
olpasiran
4
Indication
CVD
5
Economics
Licensed to AMGN, sold royalty stake to RPRX
6
MOA
apolipoprotein A
7
Clinical Trials
8
Phase III outcomes study
Martin Shkreli